Filtered By:
Specialty: Internal Medicine
Source: Mayo Clinic Proceedings
Drug: Proton Pump Inhibitors PPIs
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Association of Proton Pump Inhibitors With Higher Risk of Cardiovascular Disease and Heart Failure
To examine associations of cumulative exposure to proton pump inhibitors (PPIs) with total cardiovascular disease (CVD; composed of stroke, coronary heart disease, and heart failure [HF]) and HF alone in a cohort study of White and African American participants of the Atherosclerosis Risk in Communities (ARIC) study.
Source: Mayo Clinic Proceedings - October 1, 2021 Category: Internal Medicine Authors: Elizabeth J. Bell, Suzette J. Bielinski, Jennifer L. St. Sauver, Lin Y. Chen, Mary R. Rooney, Nicholas B. Larson, Paul Y. Takahashi, Aaron R. Folsom Tags: Original article Source Type: research
